Bill Text: US HB7658 | 2021-2022 | 117th Congress | Introduced
Bill Title: To amend the Federal Food, Drug, and Cosmetic Act to reauthorize the Critical Path Public-Private Partnerships.
Spectrum: Bipartisan Bill
Status: (Introduced - Dead) 2022-05-03 - Referred to the House Committee on Energy and Commerce. [HB7658 Detail]
Download: US_Congress-2021-HB7658-Introduced.pdf